Skip to main content

Table 2 IS, IV, RA, I < O and CFI calculated for wrist temperature, motor activity, body position and the composite variable TAP rhythms for the whole group (n = 24), and for each sex

From: Relevance of internal time and circadian robustness for cancer patients

  

Temperature (mean ± SEM)

Motor activity (mean ± SEM)

Body position (mean ± SEM)

TAP (mean ± SEM)

  

Before

During

After

Before

During

After

Before

During

After

Before

During

After

WHOLE GROUP (n = 24)

IS

0.58 ± 0.04 ab

0.56 ± 0.03 a

0.63 ± 0.03 b

0.39 ± 0.02a

0.39 ± 0.02a

0.41 ± 0.02a

0.48 ± 0.04a

0.48 ± 0.03a

0.48 ± 0.04a

0.62 ± 0.03a

0.57 ± 0.03a

0.62 ± 0.03a

IV

0.18 ± 0.02 a

0.20 ± 0.02 ab

0.21 ± 0.02 b

1.01 ± 0.03 ab

1.10 ± 0.05 a

1.01 ± 0.05 b

0.41 ± 0.03a

0.46 ± 0.03a

0.47 ± 0.03a

0.35 ± 0.03 a

0.43 ± 0.03 b

0.37 ± 0.03 a

RA

0.33 ± 0.03 a

0.26 ± 0.03 b

0.32 ± 0.03 ab

0.62 ± 0.03a

0.57 ± 0.03a

0.63 ± 0.03a

0.44 ± 0.03a

0.40 ± 0.03a

0.42 ± 0.03a

0.51 ± 0.03a

0.46 ± 0.03a

0.51 ± 0.03a

CFI

0.61 ± 0.02 ab

0.57 ± 0.02 a

0.62 ± 0.02 b

0.50 ± 0.03a

0.47 ± 0.03a

0.51 ± 0.03a

0.57 ± 0.03a

0.55 ± 0.02a

0.56 ± 0.02a

0.65 ± 0.03a

0.60 ± 0.02a

0.65 ± 0.02a

I < O

---

---

---

83.88 ± 3.22a

78.26 ± 2.93a

80.35 ± 2.63a

---

---

---

91.61 ± 3.10a

88.74 ± 2.89a

90.71 ± 2.19a

MEN (n = 11)

IS

0.56 ± 0.05a1

0.53 ± 0.05a1

0.63 ± 0.05a1

0.32 ± 0.02 a1

0.36 ± 0.02 ab1

0.40 ± 0.04 b1

0.43 ± 0.07ª1

0.46 ± 0.04a1

0.47 ± 0.06a1

0.55 ± 0.04a1

0.52 ± 0.04a1

0.58 ± 0.06a1

IV

0.15 ± 0.02 a1

0.18 ± 0.03 ab1

0.22 ± 0.02 b1

1.12 ± 0.04a1

1.17 ± 0.08a1

1.09 ± 0.08a1

0.45 ± 0.04a1

0.49 ± 0.06a1

0.55 ± 0.05a1

0.45 ± 0.04a1

0.50 ± 0.06a1

0.46 ± 0.04a1

RA

0.34 ± 0.04a1

0.28 ± 0.03a1

0.30 ± 0.03a1

0.51 ± 0.05a1

0.55 ± 0.05a1

0.55 ± 0.06a1

0.41 ± 0.06a1

0.40 ± 0.05a1

0.41 ± 0.05a1

0.44 ± 0.05a1

0.44 ± 0.05a1

0.48 ± 0.05a1

CFI

0.61 ± 0.03a1

0.58 ± 0.04a1

0.61 ± 0.03a1

0.42 ± 0.03a1

0.44 ± 0.05a1

0.47 ± 0.05a1

0.54 ± 0.05a1

0.53 ± 0.05a1

0.53 ± 0.04a1

0.59 ± 0.04a1

0.57 ± 0.05a1

0.61 ± 0.05a1

I < O

---

---

---

75.04 ± 5.95a1

75.00 ± 5.76a1

76.26 ± 3.99a1

---

---

---

84.51 ± 6.19a1

85.61 ± 5.65a1

85.98 ± 3.77a1

WOMEN (n = 13)

IS

0.59 ± 0.06ª1

0.58 ± 0.04a1

0.64 ± 0.04a1

0.44 ± 0.02a2

0.41 ± 0.02a1

0.42 ± 0.03a1

0.53 ± 0.04a1

0.50 ± 0.03a1

0.48 ± 0.05a1

0.68 ± 0.04a2

0.61 ± 0.03a1

0.65 ± 0.04a2

IV

0.20 ± 0.03a1

0.22 ± 0.03a1

0.19 ± 0.03a1

0.92 ± 0.03a2

1.03 ± 0.05a1

0.93 ± 0.05a1

0.37 ± 0.03a1

0.44 ± 0.03a1

0.41 ± 0.03a2

0.27 ± 0.03 a2

0.37 ± 0.03 b2

0.30 ± 0.02 a2

RA

0.32 ± 0.04 a1

0.24 ± 0.03 b1

0.33 ± 0.03 a1

0.71 ± 0.03 a2

0.60 ± 0.05 b1

0.69 ± 0.03 ab2

0.47 ± 0.04a1

0.41 ± 0.04a1

0.44 ± 0.04a1

0.57 ± 0.03 a2

0.47 ± 0.03 b1

0.54 ± 0.04 ab1

CFI

0.60 ± 0.04a1

0.57 ± 0.03a1

0.62 ± 0.03a1

0.56 ± 0.03 a2

0.50 ± 0.03 b1

0.55 ± 0.03 ab1

0.60 ± 0.04a1

0.57 ± 0.03a1

0.57 ± 0.04a1

0.70 ± 0.03 a2

0.63 ± 0.03 b1

0.68 ± 0.03 ab1

I < O

---

---

---

91.36 ± 1.25 a2

81.02 ± 2.39 b1

83.82 ± 3.34 ab1

---

---

---

97.62 ± 0.65 a2

91.39 ± 2.41 b1

94.72 ± 2.02 ab2

  1. Repeated-measures ANOVA and post hoc Bonferroni were performed to verify the differences among periods for the whole group or for each sex. Statistical significance was set at p < 0.05
  2. Different letters indicate statistically significant differences between periods (also highlighted in bold.) Different numbers indicate significant differences between men and women for each variable and studied period